BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.23+0.01 (+0.82%)
Close on Nov 18, 2026Market cap $27.88MP/E –Yield –
BioHarvest Sciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$5.58M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.58M | – |
| FY2024 | Dec 31, 2024 | -$6.99M | – |
| FY2023 | Dec 31, 2023 | -$9.97M | – |
See a number that looks wrong?